Advocates Push for Insurance Coverage for Fertility Preservation
倡議者推動將生育能力保存納入保險給付範圍
For many patients facing life-saving treatments like chemotherapy, a hidden challenge exists: iatrogenic infertility, or infertility caused by medical care.
對於許多面臨化學治療等救命療法的患者來說，存在著一個隱藏的挑戰：醫源性不孕症，即由醫療護理所引起的不孕。
Medical experts now consider fertility preservation, such as cryopreservation, a standard of care.
醫學專家目前將生育力保存（如冷凍保存）視為護理標準。
However, insurance companies often label these procedures as elective, leaving patients with bills ranging from $10,000 to $20,000.
然而，保險公司常將這些程序標記為非必要手術，使患者需承擔一萬至兩萬美元的帳單。
They compare it to breast reconstruction after a mastectomy, which is widely covered by insurance.
他們將其與乳房切除術後的乳房重建相比，後者已獲得保險廣泛覆蓋。
Currently, there is no federal law mandating this coverage, forcing advocates to pursue state-by-state legislation.
目前，尚無聯邦法律強制要求此類給付，迫使倡議者必須推動各州的立法。
Furthermore, there is a push to close the Medicaid gap to ensure lower-income patients are not left behind.
此外，目前正推動縮小醫療補助差距（Medicaid gap），以確保低收入患者不會被遺落。
As the conversation evolves, the focus remains on equity, ensuring that a life-saving diagnosis does not permanently end someone's hope of building a family in the future.
隨著討論的發展，重點仍在於公平性，確保診斷出需要救命治療的患者，其未來建立家庭的希望不會因此永遠終結。
